Aktiesnakken — September 2010
-
Vandmand ,jeg mener du tager fejl.meddelelsen siger ikke ar data er dårlige for at de IKKE når end point,men at de er gode og korrekte og re
-
relevante men antyder samme som tidligere nævnt at de måske bare skulle have valgt en dosis så var p-værdien godkendt eller indlagt forbehol
-
forbehold for justering for CAG så var den også god nok.Det vi nu savner er bare at få resultaterne bekræftet i det forlængede studie!!
-
@fiskemanden : jeg er sikker på at der kommer en redegørelse fra een af de lidt tungere drenge udi Neuro her på siden
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind